Literature DB >> 10535234

Contingency management, self-control, and education support in the treatment of childhood phobic disorders: a randomized clinical trial.

W K Silverman1, W M Kurtines, G S Ginsburg, C F Weems, B Rabian, L T Serafini.   

Abstract

This study evaluated the relative efficacy of an exposure-based contingency management (CM) treatment condition and an exposure-based cognitive self-control (SC) treatment condition relative to an education support (ES) control condition for treating children with phobic disorders. Eighty-one children and their parents completed a 10-week treatment program in which children and parents were seen in separate treatment sessions with the therapist, followed by a brief conjoint meeting. Children in both the CM and SC conditions showed substantial improvement on all of the outcome measures. These gains were maintained at 3-, 6-, and 12-month follow-ups. Interestingly, children in the ES condition also showed comparable improvements at posttreatment and at 3-, 6-, and 12-month follow-ups. Implications of the findings are discussed with respect to knowledge development and clinical practice.

Entities:  

Mesh:

Year:  1999        PMID: 10535234     DOI: 10.1037//0022-006x.67.5.675

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  71 in total

Review 1.  Evidence-based treatment for mental disorders in children and adolescents.

Authors:  Gregory A Fabiano; William E Pelham
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 2.  Treating childhood shyness and related behavior: empirically evaluated approaches to promote positive social interactions.

Authors:  L A Greco; T L Morris
Journal:  Clin Child Fam Psychol Rev       Date:  2001-12

3.  Randomized controlled trial: Multimodal Anxiety and Social Skill Intervention for adolescents with autism spectrum disorder.

Authors:  Susan W White; Thomas Ollendick; Anne Marie Albano; Donald Oswald; Cynthia Johnson; Michael A Southam-Gerow; Inyoung Kim; Lawrence Scahill
Journal:  J Autism Dev Disord       Date:  2013-02

4.  Specific phobia in youth: phenomenology and psychological characteristics.

Authors:  Thomas H Ollendick; Natoshia Raishevich; Thompson E Davis; Cristian Sirbu; Lars-Göran Ost
Journal:  Behav Ther       Date:  2009-10-08

5.  Primary Versus Secondary Diagnosis of Generalized Anxiety Disorder in Youth: Is the Distinction an Important One?

Authors:  Thomas H Ollendick; Matthew A Jarrett; Bradley A White; Susan W White; Amie E Grills
Journal:  Child Psychiatry Hum Dev       Date:  2016-08

Review 6.  Cognitive change and enhanced coping: missing mediational links in cognitive behavior therapy with anxiety-disordered children.

Authors:  Pier J Prins; Thomas H Ollendick
Journal:  Clin Child Fam Psychol Rev       Date:  2003-06

7.  Trajectories of change in youth anxiety during cognitive-behavior therapy.

Authors:  Tara S Peris; Scott N Compton; Philip C Kendall; Boris Birmaher; Joel Sherrill; John March; Elizabeth Gosch; Golda Ginsburg; Moira Rynn; James T McCracken; Courtney P Keeton; Dara Sakolsky; Cynthia Suveg; Sasha Aschenbrand; Daniel Almirall; Satish Iyengar; John T Walkup; Anne Marie Albano; John Piacentini
Journal:  J Consult Clin Psychol       Date:  2014-12-08

8.  Disorder-specific effects of CBT for anxious and depressed youth: a meta-analysis of candidate mediators of change.

Authors:  Brian C Chu; Tara L Harrison
Journal:  Clin Child Fam Psychol Rev       Date:  2007-12

9.  The relations among measurements of informant discrepancies within a multisite trial of treatments for childhood social phobia.

Authors:  Andres De Los Reyes; Candice A Alfano; Deborah C Beidel
Journal:  J Abnorm Child Psychol       Date:  2010-04

10.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.